. A Phase 1 Safety Trial of the aβ Oligomer Receptor Antagonist CT1812. Alzheimer's & Dementia, July 2017, Volume 13, Issue 7

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

Therapeutics

  1. Elayta